End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.4 CNY | -2.73% | -8.94% | -2.51% |
Business Summary
Number of employees: 1,057
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chidamide
89.1
%
| 467 | 88.1 % | 467 | 89.1 % | -0.04% |
Siglita Sodium
8.1
%
| 16 | 3.0 % | 42 | 8.1 % | +167.04% |
Technology Licensing
1.3
%
| 44 | 8.3 % | 7 | 1.3 % | -84.89% |
Other Business
1.2
%
| 4 | 0.7 % | 6 | 1.2 % | +75.02% |
Other
0.4
%
| - | - | 2 | 0.4 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
98.7
%
| 482 | 91.6 % | 511 | 98.7 % | +5.92% |
Taiwan
0.7
%
| 4 | 0.8 % | 3 | 0.7 % | -22.06% |
United States
0.7
%
| 40 | 7.6 % | 3 | 0.7 % | -91.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Qiang Ning
FOU | Founder | 64 | 01-03-20 |
Xian Ping Lu
CEO | Chief Executive Officer | 61 | 01-03-20 |
Jian Xun Li
DFI | Director of Finance/CFO | 53 | 01-05-31 |
De Si Pan
CTO | Chief Tech/Sci/R&D Officer | 54 | 02-04-30 |
Shu Mei Zhao
ADM | Chief Administrative Officer | 61 | 01-07-31 |
Liang Ji She
PRN | Corporate Officer/Principal | 59 | 13-11-30 |
Zhi Bin Li
PRN | Corporate Officer/Principal | 60 | 01-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Li Xin Tian
BRD | Director/Board Member | 58 | 18-03-23 |
Xian Ping Lu
CEO | Chief Executive Officer | 61 | 01-03-20 |
Jian Xun Li
DFI | Director of Finance/CFO | 53 | 01-05-31 |
Rui Lin Song
BRD | Director/Board Member | 61 | 18-06-25 |
Xun Zhu
BRD | Director/Board Member | 66 | 18-03-23 |
De Si Pan
CTO | Chief Tech/Sci/R&D Officer | 54 | 02-04-30 |
Jie He
CHM | Chairman | 39 | - |
Xiang Yan Li
BRD | Director/Board Member | 45 | 18-03-23 |
Zheng Sheng Xie
BRD | Director/Board Member | 58 | 21-03-17 |
Xia Jin
BRD | Director/Board Member | 47 | 21-03-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 411,286,794 | 252,062,800 ( 61.29 %) | 3,750,000 ( 0.9118 %) | 61.29 % |
Company contact information
Shenzhen Chipscreen Biosciences Co., Ltd.
Rm 601-606, Building 2 Shenzhen Bio Incubation Base
518057, Shenzhen
+
http://www.chipscreen.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.51% | 1.24B | |
+9.28% | 8.74B | |
-15.14% | 4.94B | |
+50.73% | 4.7B | |
+4.36% | 3.98B | |
-26.13% | 2.28B | |
+12.07% | 2.28B | |
+16.45% | 2.14B | |
-33.59% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688321 Stock
- Company Shenzhen Chipscreen Biosciences Co., Ltd.